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Abstract
Background: Creatine is a key intermediate in energy metabolism and supplementation of creatine has been used for 
increasing muscle mass, strength and endurance. Creatine supplementation has also been reported to trigger the 
skeletal muscle expression of insulin like growth factor I, to increase the fat-free mass and improve cognition in elderly, 
and more explorative approaches like transcriptomics has revealed additional information. The aim of the present 
study was to reveal additional insight into the biochemical effects of creatine supplementation at the protein and 
metabolite level by integrating the explorative techniques, proteomics and NMR metabonomics, in a systems biology 
approach.
Methods: Differentiated mouse myotube cultures (C2C12) were exposed to 5 mM creatine monohydrate (CMH) for 24 
hours. For proteomics studies, lysed myotubes were analyzed in single 2-DGE gels where the first dimension of protein 
separation was pI 5-8 and second dimension was a 12.5% Criterion gel. Differentially expressed protein spots of 
significance were excised from the gel, desalted and identified by peptide mass fingerprinting using MALDI-TOF MS. 
For NMR metabonomic studies, chloroform/methanol extractions of the myotubes were subjected to one-dimensional 
1H NMR spectroscopy and the intracellular oxidative status of myotubes was assessed by intracellular DCFH2 oxidation 
after 24 h pre-incubation with CMH.
Results: The identified differentially expressed proteins included vimentin, malate dehydrogenase, peroxiredoxin, 
thioredoxin dependent peroxide reductase, and 75 kDa and 78 kDa glucose regulated protein precursors. After CMH 
exposure, up-regulated proteomic spots correlated positively with the NMR signals from creatine, while down-
regulated proteomic spots were negatively correlated with these NMR signals. The identified differentially regulated 
proteins were related to energy metabolism, glucose regulated stress, cellular structure and the antioxidative defence 
system. The suggested improvement of the antioxidative defence was confirmed by a reduced intracellular DCFH2 
oxidation with increasing concentrations of CMH in the 24 h pre-incubation medium.
Conclusions: The explorative approach of this study combined with the determination of a decreased intracellular 
DCFH2 oxidation revealed an additional stimulation of cellular antioxidative mechanisms when myotubes were 
exposed to CMH. This may contribute to an increased exercise performance mediated by increased ability to cope with 
training-induced increases in oxidative stress.
Background
Creatine is predominantly situated in skeletal muscle, and
originates from both endogenous de novo synthesis and
exogenous sources, which are mainly animal products [1].
Creatine and its phosphorylated form are well recognized
as key intermediates in the energy metabolism of muscle
fibres. Supplementation of creatine has been widely used
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among athletes as a means for increasing muscle mass
and muscle strength and muscle endurance [2-4], but also
for elderly people creatine supplementation, seems to
enhance muscle strength [5]. The rationale behind CMH
supplementation is to increase the content of creatine
phosphate in the muscle, and several studies have also
shown that the creatine content of the muscle is
increased [6], and the majority of this is as creatine phos-
phate [1,2]. However, creatine supplementation has also
been reported to trigger the expression of insulin like
growth factor I (IGF-1) in young adults [7], increase fat-
free mass [8] and improve cognition in the elderly [9].
Some of these findings have been supported by mecha-
nistic studies in various muscle cell cultures, where IGF-1
[10], myogenesis [11] and protein synthesis [10,12,13]
were increased, and also a more explorative approach
using microarrays on muscle biopsies from creatine sup-
plemented individuals revealed cytoskeleton remodel-
ling, protein and glycogen synthesis regulation, as well as
cell proliferation and differentiation [8]. Other techniques
such as proteomics and metabonomics may reveal addi-
tional insight into some of the biochemical effects of cre-
atine supplementation at the protein and metabolite level.
High-resolution 1H nuclear magnetic resonance (NMR)
spectroscopy is a well-established analytical technique for
metabolic fingerprinting of biofluids and various tissues
and has also been used for elucidating the metabolic
effects of dietary factors in both humans [14-17], animals
[18-20], and also in cell cultures [21]. These studies have
demonstrated that NMR-based metabonomics is
extremely efficient in detecting endogenous and exoge-
neous metabolic perturbations. However, while being
capable of identifying biomarkers and metabolic pertur-
bations, the metabolic network responsible for the per-
turbations can only be hypothesised. Proteomics displays
protein products as a result of gene expression and effi-
ciency of translation, and has been used to separate and
identify differentially regulated proteins in response to
various treatments of cultured cells [22,23] and muscles
[24]. Linking information obtained from metabolic fin-
gerprinting with proteomics would pave the way for
obtaining a better understanding of the primary pathways
involved in perturbations associated with CMH supple-
mentation. In this study we have for the first time exam-
ined and integrated the NMR metabolite profile and the
proteomic profile of myotubes in the presence and
absence of creatine supplementation in a systems biology
approach.
Methods
Muscle Cell Culture
Myotube cultures were established from a mouse myo-
blast line (C2C12) originally derived from a thigh muscle
[25] (American Type Culture Collection, Manassas, VA).
A clone from this cell line, which effectively fused and
formed myotubes, was isolated [26]. The clone was
grown in 80 cm2 culture flask in 10 mL of medium con-
sisting of Dulbecco's modified Eagle's medium (DMEM),
10% (vol/vol) fetal calf serum (FCS), and supplemented
with 1% antibiotics giving 100 IU/mL penicillin, 100 μg/
mL streptomycin sulfate, 3 μg/mL amphotericin B, and
20  μg/mL gentamycin (growth medium). Cells were
maintained in an atmosphere of 95% air and 5% CO2 at
37°C. Prior to confluence, cells were harvested in 0.25%
trypsin and sub-cultured into 80 cm2 culture flasks or 96
well plates. Cells were grown to confluence in growth
medium, and left to fuse in medium containing 4% FCS
(differentiation medium) without phenol red. Following
approximately 6 days, the cultures contained differenti-
ated multinuclear myotubes and were ready for experi-
mental use. Culture medium was changed every other
day throughout the culture period.
Myotube treatment and sampling for proteomics and 
metabonomics
For 24 hours the fully differentiated myotubes were cul-
tured in the presence or absence of 5 mM creatine mono-
hydrate (CMH) in the differentiation medium. The
treatment and controls were performed in triplicate. Cells
were washed in PBS and harvested in 10 ml phosphate
buffered saline (PBS) by scraping the flask and mixed
thoroughly. The protein content of the cell suspensions
was analyzed by the bicinchoninic acid assay (BCA) (Bio-
Rad). Five aliquots of 200 μL of each of the triplicates
were centrifuged at 6.000 × g for 5 min at 4°C. The cell
pellet was kept at -80°C for proteome analysis. The
remaining approximately 9 mL was centrifuged at 1000 ×
g for 10 min at 4°C. The pellet was washed in 1 mL D2O
including 0.9% NaCl, centrifuged at 6.000 × g for 5 min
and the pellet was kept at -80°C for metabonome analysis.
Two-dimensional gel electrophoresis (2-DGE)
The stored cell pellets were thawed, and 100 μL of lysis
buffer (6 M urea, 2 M thiourea, 1.5% (w/v) pharmalyte,
0.8% (w/v) 3-[(3-cholamidopropyl) dimethylammonio]-1-
propansulfonate (CHAPS), 1% (w/v) dithioerythritol
(DTE) in water) was added to triplicate samples. After
incubation for 2 h at room temperature, the desired
amount of protein from the two aliquots of each sample
was combined and further diluted in a rehydration buffer
to a final volume of 185 μL. The rehydration buffer con-
sisted of the same substances, in same concentrations as
the lysis buffer, but with pharmalyte (5 μL/mL) instead of
1% DTE. For analytical gels subjected to image analysis, a
volume of the lysed cell fraction corresponding to 50 μg
protein was applied. For preparative gels used for mass
spectrometry (MS) analysis a volume corresponding to
125 μg protein was applied. The lysed cells were analyzed
in single 2-DGE gel sets consisting of 6 gels representingYoung et al. Journal of the International Society of Sports Nutrition 2010, 7:9
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the three biological replicates of either control cells or
CMH treated cells. The first dimension of protein separa-
tion was carried out in immobilized 11 cm IPG strips (pH
5-8), whereas 12.5% Criterion gels (BioRad) were used for
the second dimension. Running conditions for the 2-DGE
gels were essentially as described earlier [27]. Analytical
gels were silver stained according to Lametsch and Ben-
dixen [27], whereas preparative gels were stained accord-
ing to Shevchenko et al.[28].
In gel digestion, desalting and concentration of protein 
spots
Protein spots of significance were subjected to in-gel
digestion by addition of trypsin essentially as described
by Jensen et al. [29]. Custom-made chromatographic col-
umns were used for desalting and concentration of the
peptide mixture prior to MS analysis as described by
Lametsch et al. [30]. The peptides were eluted in 0.5 μL
matrix solution (15-20 g/L of α-cyano-4-hydroxycin-
namic acid in 70% acetonitrile) directly onto the MALDI
target plate.
Identification of myotube proteins by MALDI-TOF mass 
spectrometry
Mass spectra were obtained using a Bruker Ultraflex
MALDI-TOF tandem mass spectrometer in reflection
mode. A peptide calibration standard (0.2 μl) containing
seven standard peptides ranging in molecular mass from
1046.54 to 3147.47 Da was spotted separately onto the
MALDI target plate. The ion accelerating voltage was 25
kV with a delay time of 40 ns. The laser frequency was 50
Hz and 200 laser shots were accumulated for each spec-
trum. Proteins were identified by peptide mass finger-
printing (PMF) by mass searches in the database Swiss
Prot (Swiss Institute of Bioinformatics, Genève, Switzer-
land) using the search program Mascot (Matrix Science,
Boston, USA). In this program the experimental mass
value, obtained from MS, is compared with calculated
peptide masses from a database. A scoring algorithm is
used to identify the closest match. Significant protein
identifications (protein scores above 60, P < 0.05) were
reported, and manually verified.
Image analysis
The 2-DGE gels were photographed by a Vilber Lourmat
digital camera (ImageHouse, Copenhagen, Denmark)
equipped with Gel Pro analyzer software. The gel spots
were detected and quantified using ImageMaster 2D pla-
timum software (Amersham Pharmacia Biotech, Uppsala,
Sweden). After initial analysis using automated spot
detection and segmentation, all images were manually
checked and the spots were matched by comparing the
relative positions of the individual spots on each gel,
which reduced the number of spots used in the further
analysis. The spots were quantified by adding the pixel
intensities within the spot boundary, and the spot vol-
umes were calculated. To overcome gel-to-gel variations
in spot intensities due to technical variations related to
the staining procedure, the relative spot volumes were
calculated for each separate spot on the gels and these
values were used in the further data analysis.
NMR measurements
Cells were extracted prior to NMR measurements using a
dual methanol/chloroform extraction. The culture dishes
were placed on liquid nitrogen and cells were added 2 mL
of cold chloroform/methanol (1:1, vol/vol). The cells were
homogenized using an electrical homogenizer, and cen-
trifuged for 20 min at 1300 g at 4°C. After centrifugation
the supernatants were collected and the pellets were
resuspended with 1 mL of chloroform/methanol, centri-
fuged, and the supernatants were collected. The superna-
tant was washed with 1 mL ice-cold water, and the water
phase was removed and added to the pellet. Two mL of
water was added, the pellet was centrifuged, the superna-
tant was freeze-dried and subsequently dissolved in 0.6
mL D2O containing 0.5 mM sodium trimethylsilyl-
[2,2,3,3-2H4]-1-propionate (TMSP), and analyzed by 1H
NMR.
The NMR measurements were performed at 300 K on a
Bruker Avance 400 NMR Spectrometer (Bruker BioSpin),
operating at a 1H frequency of 400.13 MHz, and equipped
with a standard 5-mm HX inverse probe. One-dimen-
sional 1H NMR spectra were obtained using a single 90°
pulse experiment, solvent suppression was achieved by
irradiating the solvent peak during the relaxation delay of
2 s. A total of 128 transients of 8 K data points spanning a
spectral width of 24.03 ppm were collected. An exponen-
tial line-broadening function of 1 Hz was applied to the
free induction decay (FID) prior to Fourier transform
(FT). All spectra were referenced in chemical shift value
to the TMSP signal at 0 ppm. The 1H NMR spectra in the
10.0-5.0 and 4.5-0.5 ppm regions were subdivided into
0.005 ppm integral regions and integrated, reducing each
spectrum into 616 independent variables. The reduced
spectra were normalized to total intensity to remove any
concentration effects.
DCFH2 oxidation analysis
Differentiated myotubes in 96 well plates were analyzed
as described earlier [31]. Briefly, myotubes were pre-incu-
bated with different concentrations of CMH (0.04-10
μM) for 24 h. Myotubes were then washed and loaded
with 10 μM 2',7'dichlorodihydroflourescein diacetate
(Molecular Probes, Inc. Eugene, OR) (H2DCF-DA) for 2 h
at 37°C (95% air, 5% CO2) washed again, 100 μM H2O2
was added and intracellular DCFH2 oxidation was deter-
mined by fluorescence from 2,7-dichloroflourescein
(DCF) at excitation and emission wavelengths of 490 and
515 nm, respectively, at 37°C with a microtiter plate
reader (Synergy 2, BioTek Instruments Inc., Vermont,Young et al. Journal of the International Society of Sports Nutrition 2010, 7:9
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USA). Data is presented as average of 12 replicate wells
after background correction.
Data analyses
Multivariate data analysis was performed using the
Unscrambler software version 9.2 (Camo, Oslo, Norway).
Partial least squares-discriminant analysis (PLS-DA) was
performed on the metabonomic and the proteomic data
to explore intrinsic biochemical dissimilarities between
control cells and CMH treated cells. For the metabo-
nomic data, the NMR signals were used as continuous X-
parameters, while the treatment consisted the discrimi-
nant regressors (control = 0, treated = 1). For the pro-
teomic data, the relative spot volumes obtained by image
analysis of the 2-DGE gels were used as continuous X-
parameters. Protein spots contributing least to the PLS-
DA models were removed by Jack-knifing [32] through
variable selection until an optimal calibrated and vali-
dated model was achieved, and based on the remaining
spots significant (P < 0.05) regression coefficients were
identified using the uncertainty test. For elucidation of
correlations between metabonomic and proteomic data,
a PLS-2 regression was carried out with NMR variables as
X and proteomic spots identified as significant from the
D-PLS model as y-variables. A students' t-test was carried
out to compare the concentrations of each myotube pro-
tein in the triplicate controls and CMH treated C2C12
cells. A two-tailed paired t-test was used with a 0.95%
confidence interval.
Results
Myotubes exposed to creatine clearly changed their over-
all metabolic profile as reflected in the PLS-DA on the
NMR-based metabonomic data (Figure 1A), where the
discrimination between the control myotubes and CMH
treated myotubes was evident. The loading plot (Figure
1B) revealed that signals at 3.04 ppm and 3.94 ppm domi-
nates the discrimination, and this can be ascribed to a
higher content of creatine in the treated cells, confirming
the expected increased incorporation of creatine into the
myotubes. The myotube protein expression in response
to creatine was analyzed by proteomics using 2-DGE. An
obtained proteomic profile of myotube extracts is shown
in Figure 2.
After the manual check of the automatically assigned
number of spots, a total of 584 protein spots were anno-
tated by the image analysis and used in the further statis-
tical analysis. By PLS-DA, 28 proteins were found to be
differentially expressed when comparing CMH-treated
myotubes with the control myotubes (results not shown).
The significance of the spots identified by the PLS-DA
was further tested by statistical t-test (Table 1). Of the 28
protein spots in the PLS-DA model, 20 of these were
found to be either significantly different (P < 0.05) or
exhibited tendency to be significantly different (P < 0.1)
by the t-test. Accordingly, the t-test confirms that the
intensities of the majority of the spots identified by PLS-
DA are considerably affected by CMH treatment. Of
these, 13 were up-regulated by CMH treatment, while 7
were down-regulated. This shows, as probably expected,
that CMH stimulates the expression of more proteins
than it down-regulates. The spots which were identified
by the t-test to be differentially expressed in the myotubes
in response to CMH treatment were cut out from the
gels, and subjected to MALDI-TOF MS analysis using
peptide mass fingerprinting. Those protein spots which
were identified by MS are listed in Table 2. The identified
proteins include vimentin, malate dehydrogenase, perox-
iredoxin, thioredoxin dependent peroxide reductase, 75
kDa and 78 kDa glucose regulated protein precursors.
Moreover, in order to investigate the relationship
between the proteomic spots, identified by the PLS-DA
model and the metabolite profile of the myotubes, a PLS2
regression was carried out between the NMR metabolite
profile and the 28 differentially regulated spots. Figure 3
shows the correlations loadings for variables selected
PLS-DA scores plot of NMR-based metabonomic data Figure 1 PLS-DA scores plot of NMR-based metabonomic data. 
(A) PLS-DA scores plot from analysis of NMR-based metabonomic data 
obtained on extracts of control (open circles) and creatine monohy-
drate (CMH) treated C2C12 muscle cells (closed circles), (B) the X-load-
ings of the PLS-DA. The dominating signals at 3.04 and 3.94 ppm are 
ascribed to CH3 and CH2 in creatine, respectively. The arrow shows a 
signal at 2.40 ppm, which was also found to be significant in the dis-
crimination of control and CMH-treated cells. The 2.40 ppm signal is 
tentatively assigned to malate.
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from jack-knifing of this PLS-2 regression. Proteomic
spots found to be up-regulated with CMH are clearly pos-
itively correlated with the NMR signals from creatine
(3.05; 3.95-3.99 ppm), while proteomic spots found to be
down-regulated with CMH are negatively correlated with
these NMR signals. Noticeably, a NMR signal at 2.39
ppm, which is tentatively assigned to malate, is positively
correlated with the proteomic spots down-regulated by
CMH.
The results from the proteomic data indicate an antiox-
idative effect of CMH on the cells as two thioredoxin
reductases (peroxiredoxin-4 and thioredoxin dependent
peroxide reductase) were up-regulated. On the basis of
this, the overall intracellular antioxidative capacity was
analyzed in myotubes after pre-incubation with CMH for
24 h. The protective effect of CMH pre-incubation was
supported by a reduced intracellular DCFH2 oxidation
with increasing concentrations of CMH (Figure 4).
Discussion
The identified differentially regulated proteins (Table 2)
are related to different cellular functions. Malate dehy-
drogenase is central in the energy metabolism, GRP75
and GRP78 are glucose regulated stress proteins, the fila-
ment protein vimentin is involved in maintaining cell
integrity, and perturbation of the antioxidant defence sys-
tem is indicated by peroxiredoxin-4 and thioredoxin
dependent peroxide reductase.
The reason why malate dehydrogenase is elevated in
creatine treated cultures is not known. However, we spec-
ulate that increased re-synthesis of glycogen is involved
following treatment with CMH. This is based on the fol-
lowing considerations. In muscle creatine phosphate is an
available energy source for muscle contraction during
anaerobic conditions:
This reaction is under the control of creatine phospho-
kinase. Addition of CMH increases intra cellular concen-
trations of creatine (Figure 1) and this in turn will force
the equilibrium to the right resulting in a higher level of
creatine phosphate and ADP. Reduced ATP and increased
ADP will increase the ratio of ADP:ATP which increases
Creatine ATP Creatine Phosphate ADP +↔ +
Proteomic profile of myotubes Figure 2 Proteomic profile of myotubes. Proteomic profile of myotubes as analyzed by 2-DGE visualized by silver staining. The positions of protein 
spots identified to be significantly different in controls and in creatine monohydrate-treated myotubes by PLS-DA of 2-DGE proteomics data are indi-
cated.
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the rate of glycogenolysis. Thus, to restore ATP glycogen
is degraded causing an elevated intracellular glucose
level, which in the present study was indicated by down
regulation of the glucose regulated protein precursors
GRP75 and GRP78, both of which has been shown to
increase with glucose starvation in the cell [33].
Following ATP restoration, glyconeogenesis is stimu-
lated (by ATP). The substrate for the re-synthesis of gly-
cogen is oxaloacetate and in the mitochondria
oxaloacetate is converted to malate in order to enable the
transport to the cytoplasm. Malate is then oxidised to
oxaloacetate in the cytoplasm and this oxidation process
is catalyzed by malate dehydrogenase. Oxaloacetate is
then available as substrate for glycogen re-synthesis.
Increased expression of malate dehydrogenase in CMH
supplemented myotubes together with reduced intracel-
lular content of the reaction substrate malate as detected
by the NMR signal at 2.39 ppm. (Figure 3) support the
assumptions above.
Thus, the data related to cellular energy metabolism
broadly confirm previously described effects of CMH,
but CMH supplementation has also been associated with
cytoskeleton remodelling [8]. In the present study, struc-
tural perturbations were only indicated by an up regula-
tion of the intermediate filament protein vimentin, which
may just reflect maintenance of cellular integrity. Other
studies have shown that neither muscle hypertrophy nor
performance of rat skeletal muscle was augmented by
creatine, and the authors argued that positive findings in
relation to performance may rather be due to an
enhanced ability to train [34].
Other effects of creatine support the hypothesis of cre-
atine-induced improved ability to train through a direct
Correlation loading plot of PLS2 (X: NMR variables, Y: selected proteomic spots) Figure 3 Correlation loading plot of PLS2 (X: NMR variables, Y: selected proteomic spots). Correlation loading plot (1st and 2nd PLS component) 
of PLS2 using NMR variables as X and selected proteomic spots as Y. Jack knifing has been applied to eliminate insignificant variables. The inner and 
outer ellipses refer to 50 percent and 100 percent explained variance in X and Y, respectively. The validated explained variances are 100%/0% for X 
and 51%/18% for Y, the 1st and the 2nd component, respectively.
 
Intracellular oxidation of 2,7-dichloroflourescein Figure 4 Intracellular oxidation of 2,7-dichloroflourescein. Oxida-
tion of intracellular 2,7-dichloroflourescein in myotube cultures ex-
posed to 100 μM H2O2 after pre-incubation with increasing amounts of 
creatine monohydrate (CMH) for 24 h.
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antioxidant effect of creatine [35] on DNA molecules [36]
or through activation of some of the cellular antioxidative
systems.
The intracellular protection mechanisms against reac-
tive oxygen species are very delicately balanced and,
when exposed to stressors, adjustments in the defense
mechanisms may be induced [37]. In various cell cultures
including murine myoblasts an increased creatine level
was associated with general cytoprotective effects
towards oxidative agents [38,39]. However, the activities
of the antioxidative enzymes catalase and glutathionper-
oxidase were not affected by creatine treatment [38,39],
and the authors ascribed the cytoprotective effect to
scavenging dependent antioxidative mechanisms [38]. In
the present study on murine myotubes, we revealed an
additional antioxidant effect of creatine, i.e. its capacity to
induce up-regulation of one of the cellular antioxidative
systems the thiol redox system, which consists of the glu-
tathione and thioredoxin pathways [40]. Two thioredoxin
reductases situated in the mitochondria and cytoplasm,
respectively, were increased in creatine treated cells
(Table 1); peroxiredoxin-4, a type 2 peroxiredoxin, and
thioredoxin dependent peroxide reductase. These sys-
tems catalyse thiol-disulfide exchange reactions and
Table 1: Relative protein spot volumes of spots identified by PLS-DA
S p o t  I D M e a n  C S DM e a n  C M H S Dn C→CMH1 P-value
156 0.140 0.042 0.271 0.005 3 ↑ 0.028
171 0.182 0.027 0.138 0.022 3 ↓ 0.004
267 0.309 0.248 0.811 0.233 3 ↑ 0.019
376 0.362 0.169 0.109 0.010 3 ↓ 0.120
408 0.400 0.072 0.380 0.165 3 ↓ 0.828
413 0.058 0.011 0.0716 0.002 3 ↑ 0.113
440 0.048 0.004 0.077 0.010 3 ↑ 0.042
458 0.118 0.003 0.102 0.002 3 ↓ 0.015
461 0.051 0.008 0.069 0.006 3 ↑ 0.134
483 0.072 0.005 0.087 0.004 3 ↑ 0.021
515 0.192 0.027 0.255 0.016 3 ↑ 0.079
522 0.410 0.008 0.587 0.081 3 ↑ 0.073
573 0.079 0.008 0.135 0.004 3 ↑ 0.002
659 0.091 0.005 0.107 0.005 3 ↑ 0.115
667 0.140 0.005 0.170 0.012 3 ↑ 0.038
673 0.140 0.027 0.187 0.006 3 ↑ 0.086
680 0.255 0.009 0.302 0.004 3 ↑ 0.006
767 0.062 0.005 0.040 0.012 3 ↓ 0.030
878 0.277 0.086 0.094 0.025 3 ↓ 0.055
895 0.175 0.011 0.114 0.016 3 ↓ 0.011
897 0.181 0.049 0.085 0.011 3 ↓ 0.066
900 0.087 0.008 0.048 0.011 3 ↓ 0.025
903 0.068 0.020 0.152 0.028 3 ↑ 0.086
923 0.070 0.018 0.153 0.031 3 ↑ 0.038
924 0.029 0.006 0.064 0.011 3 ↑ 0.015
941 0.566 0.184 0.078 0.134 3 ↓ 0.114
948 0.080 0.020 0.120 0.008 3 ↑ 0.126
951 0.047 0.021 0.045 0.024 3 ↓ 0.9
1, direction of change of relative spot volume in samples in relation to CHM treatment (C, data from control cells; CMH, data from CMH treated cells).Young et al. Journal of the International Society of Sports Nutrition 2010, 7:9
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thereby control the redox state of cytoplasmic cysteine
residues, thus protecting e.g. radical sensitive enzymes
from oxidative damage. An up-regulation of these very
universally important redox systems as well as reduced
intracellular DCFH2 oxidation (Figure 4) is an indication
of an improved resistance towards oxidative challenges in
cells exposed to CMH. Improvement of the intracellular
antioxidative mechanisms will enhance the ability to cope
with the increased levels of reactive oxygen species inevi-
tably following increased exercise.
Conclusions
CMH supplementation increases the muscle cell energy
metabolism, but the direct effect on performance is still
debated and investigated. The explorative approach of
this study, combined with the finding of a decreased
intracellular DCFH2  oxidation, revealed an additional
stimulation of cellular antioxidative mechanisms when
exposed to CMH. This may contribute to an improved
performance through increased ability to cope with train-
ing-induced increases in oxidative stress. Combined
effects of increased energy load and improved antioxida-
tive defences may thus be the key to the performance
improvement experienced by some athletes following
creatine supplement, but this approach needs further
investigation [41].
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Table 2: Proteins from myotubes identified by MALDI-TOF MS of spots after 2-DGE.
Spot id Protein Sequence 
coveragea
Matched 
peptidesb
Scorec Theo. pId Theo. Mwe
(kDa)
Access keyf
High in CMH
267 Vimentin 37 21 189 4.9 54 P20152
522 Malate dehydrogenase - cy-
toplasmic
21 6 65 6.2 37 Q6PAB3
667 Peroxiredoxin-4 26 6 73 6.8 31 O08807
680 Thioredoxin dependent
peroxide reductase
45 9 98 5.9 28 P20108
High in Controls
171 GRP75, 75 kDa glucose reg-
ulated protein precursor
16 10 76 5.8 74 P38674
941 GRP78, 78 kDa glucose reg-
ulated protein precursor
24 16 120 4.9 72 P06761
a, The minimum coverage of the matched peptides in relation to the full-length sequence.
b, The number of matched peptides in the database search.
c, Score of the Mascot search.
d, Theoretical pI of the full length protein.
e, Theoretical molecular mass (Mw) of the full length protein.
f, Primary accession key in the SWISS-PROT database.Young et al. Journal of the International Society of Sports Nutrition 2010, 7:9
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